This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Philippine antitrust commission greenlights GCMC, Leapfrog Healthcare venture

( February 23, 2026, 05:54 GMT | Official Statement) -- MLex summary: The Philippine Competition Commission has approved the proposed joint venture among GCMC Holdings, Navegar II Singapore and Leapfrog Emerging Consumer Fund IV following a Phase 1 review. The agency’s Mergers and Acquisitions Office found no horizontal overlaps or vertical relationships, noting the parties operate in distinct segments and that Leucadendron has no Philippine operations. The transaction is not expected to alter market dynamics, underscoring the PCC’s scrutiny of cross-border investments in critical sectors.Statement follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login